Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
1st Jun 2016 11:30 am RNS Total Voting Rights
27th May 2016 12:36 pm RNS POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA
27th May 2016 7:03 am RNS Positive results from AstraZeneca Faslodex trial
27th May 2016 7:00 am RNS AstraZeneca receives CRL from US FDA for ZS-9
23rd May 2016 4:00 pm RNS Director/PDMR Shareholding
18th May 2016 7:00 am RNS TOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL
17th May 2016 7:00 am RNS POSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA
12th May 2016 7:00 am RNS SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US
11th May 2016 5:30 pm RNS Publication of Final Terms
9th May 2016 5:35 pm RNS Launch and pricing of EUR2.2bn bond issues
5th May 2016 3:00 pm RNS Publication of a Prospectus
3rd May 2016 1:30 pm RNS Total Voting Rights
3rd May 2016 7:01 am RNS AstraZeneca completes divestment of Imdur
3rd May 2016 7:00 am RNS AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY
29th Apr 2016 5:30 pm RNS Result of AGM
29th Apr 2016 12:46 pm RNS POSITIVE CHMP OPINION FOR CAZ AVI
29th Apr 2016 7:00 am RNS AZN: 1st Quarter Results
28th Apr 2016 9:00 am RNS Notice of Results
26th Apr 2016 9:29 am RNS AZ enters US licensing agreement with Ironwood
26th Apr 2016 7:01 am RNS BEVESPI AEROSPHERE APPROVED BY US FDA FOR COPD
8th Apr 2016 7:00 am RNS AZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL
1st Apr 2016 11:30 am RNS Total Voting Rights
29th Mar 2016 7:00 am RNS TAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS
24th Mar 2016 3:00 pm RNS Director/PDMR Shareholding
23rd Mar 2016 7:00 am RNS AZ reports results from Brilinta stroke trial
18th Mar 2016 10:30 am RNS Notice of AGM
8th Mar 2016 6:29 pm RNS Filing of Form 20-F with SEC
8th Mar 2016 12:00 pm RNS Annual Financial Report
1st Mar 2016 2:30 pm RNS Total Voting Rights
29th Feb 2016 1:45 pm RNS AZ REPORTS TOP-LINE RESULT OF TREMELIMUMAB TRIAL
29th Feb 2016 7:59 am RNS AZ enters licensing agreement with CMS for Plendil
26th Feb 2016 12:00 pm RNS Director/PDMR Shareholding
25th Feb 2016 8:57 am RNS ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED
19th Feb 2016 7:05 am RNS BRILIQUE APPROVED IN EU FOR HEART ATTACK PATIENTS
19th Feb 2016 7:00 am RNS ZURAMPIC APPROVED IN EU FOR GOUT PATIENTS
17th Feb 2016 7:00 am RNS Durvalumab granted BTD by FDA for cancer patients
16th Feb 2016 8:01 am RNS NEW EXTERNAL BOARD APPOINTMENT
4th Feb 2016 7:00 am RNS AstraZeneca Full-Year and Q4 2015 Results
3rd Feb 2016 9:00 am RNS Notice of Results
3rd Feb 2016 7:00 am RNS TAGRISSO approved in EU for cancer patients
FTSE 100 Latest
Value8,837.91
Change26.87